United States · FDA National Drug Code directory
Naproxen
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-264_327a22dc-b87a-2758-e063-6394a90ae257
- Product NDC
- 76420-264
- Form
- TABLET
- Composition / generic term
- Naproxen
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200301
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 TABLET in 1 BOTTLE (76420-264-01) · 76420-264-01
- 2 TABLET in 1 BOTTLE (76420-264-02) · 76420-264-02
- 500 TABLET in 1 BOTTLE (76420-264-05) · 76420-264-05
- 7 TABLET in 1 BOTTLE (76420-264-07) · 76420-264-07
- 100 TABLET in 1 BOTTLE (76420-264-10) · 76420-264-10
- 120 TABLET in 1 BOTTLE (76420-264-12) · 76420-264-12
- 14 TABLET in 1 BOTTLE (76420-264-14) · 76420-264-14
- 20 TABLET in 1 BOTTLE (76420-264-20) · 76420-264-20
- 30 TABLET in 1 BOTTLE (76420-264-30) · 76420-264-30
- 60 TABLET in 1 BOTTLE (76420-264-60) · 76420-264-60
- 90 TABLET in 1 BOTTLE (76420-264-90) · 76420-264-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →